Dr. Kobashigawa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
127 S San Vicente Blvd
# A3107
Los Angeles, CA 90048Phone+1 310-248-3830Fax+1 310-248-8338
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1984 - 1986
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1980 - 1983
- Icahn School of Medicine at Mount SinaiClass of 1980
- Stanford UniversityB.S., 1972 - 1976
Certifications & Licensure
- CA State Medical License 1981 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FAHA) American Heart Association
- Fellow (FACC) American College of Cardiology
- Co-Chair, Thoracic Community of Practice Committee American Society for Transplantation
- Join now to see all
Clinical Trials
- A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV) Start of enrollment: 2010 Nov 01
- Home Electrocardiogram (ECG) Monitoring After Heart Transplantation Start of enrollment: 2011 Aug 01
- Heartsbreath Test for Heart Transplant Rejection Start of enrollment: 2010 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- The outcome of restrictive cardiac allograft physiology in severe coronary allograft vasculopathy.Masaki Tsuji, Jignesh K Patel, Michelle M Kittleson, David H Chang, Evan P Kransdorf
The Journal of Heart and Lung Transplantation. 2025-01-01 - Therapeutic Plasma Exchange is Associated with Increased Survival in Heart Transplant Recipients Experiencing Severe Primary Graft Dysfunction.Yosef Manla, David H Chang, Jignesh Patel, Avani Kanugo, Andriana Nikolova
The Journal of Heart and Lung Transplantation. 2024-11-17 - Donor Selection for Heart Transplantation in 2024.Rashmi Jain, Evan P Kransdorf, Jennifer Cowger, Valluvan Jeevanandam, Jon A Kobashigawa
JACC. Heart Failure. 2024-11-08
Journal Articles
- Omission of Heart Transplant Recipients from the Appropriate Use Criteria for Revascularization and the Ramifications on Heart Transplant CentersJon A Kobashigawa, Steven W Tabak, Wendy Book, John A Spertus, JAMA Cardiology
- Non‐Invasive Detection of Graft Injury After Heart Transplantation Using Donor‐Derived Cell‐Free DNA: A Prospective Multi‐Center StudyGregory Ewald, Jon Kobashigawa, Kiran K Khush, Jignesh Patel, Eugene DePasquale, Sean Pinney, American journal of transplantation
- Oxford University Press Has Registered This DOI Pre-PublicationMichelle Kittleson, Heidi Reich, Lawrence Czer, Dominick Megna, Jignesh Patel, Fardad Esmailian, Jon Kobashigawa, Oxford University Press
- Join now to see all
Authored Content
- Omission of Heart Transplant Recipients from the Appropriate Use Criteria for Revascularization and the Ramifications on Heart Transplant CentersApril 2020
- Temporal Trends of De Novo Malignancy Development After Heart TransplantationJanuary 2018
- Temporal Trends of De Novo Malignancy Development After Heart TransplantationJanuary 2018
- Temporal Trends of De Novo Malignancy Development After Heart TransplantationJanuary 2018
- Join now to see all
Press Mentions
- Smidt Heart Institute Experts Available for Interviews During ISHLT ConferenceApril 18th, 2023
- ISHLT Honors Jon Kobashigawa for Lifetime Achievement in Treating Advanced Heart DiseaseFebruary 15th, 2023
- Upcoming Life Sciences EventsMay 3rd, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: